BR9710028A - Proteínas do tipo-2 que se ligam a quimiocina e métodos para a utilização das mesmas para esse fim - Google Patents
Proteínas do tipo-2 que se ligam a quimiocina e métodos para a utilização das mesmas para esse fimInfo
- Publication number
- BR9710028A BR9710028A BR9710028A BR9710028A BR9710028A BR 9710028 A BR9710028 A BR 9710028A BR 9710028 A BR9710028 A BR 9710028A BR 9710028 A BR9710028 A BR 9710028A BR 9710028 A BR9710028 A BR 9710028A
- Authority
- BR
- Brazil
- Prior art keywords
- type
- proteins
- chemokine
- bind
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1813796P | 1996-05-22 | 1996-05-22 | |
PCT/US1997/008590 WO1997044054A2 (en) | 1996-05-22 | 1997-05-21 | Type-2 chemokine binding proteins and methods of use therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9710028A true BR9710028A (pt) | 1999-08-10 |
Family
ID=21786445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9710028A BR9710028A (pt) | 1996-05-22 | 1997-05-21 | Proteínas do tipo-2 que se ligam a quimiocina e métodos para a utilização das mesmas para esse fim |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0901379B1 (pt) |
JP (1) | JP2000511535A (pt) |
KR (1) | KR20000015895A (pt) |
CN (1) | CN1226171A (pt) |
AT (1) | ATE196091T1 (pt) |
AU (1) | AU3136197A (pt) |
BR (1) | BR9710028A (pt) |
CA (1) | CA2256568A1 (pt) |
CZ (1) | CZ378998A3 (pt) |
DE (1) | DE69703040T2 (pt) |
DK (1) | DK0901379T3 (pt) |
ES (1) | ES2152095T3 (pt) |
GR (1) | GR3034805T3 (pt) |
HK (1) | HK1017622A1 (pt) |
IL (1) | IL127166A0 (pt) |
NO (1) | NO985412L (pt) |
NZ (1) | NZ333456A (pt) |
PL (1) | PL330149A1 (pt) |
PT (1) | PT901379E (pt) |
TR (1) | TR199802392T2 (pt) |
WO (1) | WO1997044054A2 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
GB9916703D0 (en) | 1999-07-16 | 1999-09-15 | Alcami Antonio | Viral protein binding compositions and methods |
AU2001261738A1 (en) * | 2000-05-17 | 2001-11-26 | London Health Sciences Centre | Compositions and methods for promoting immunosuppression |
AU2001278905B2 (en) | 2000-09-08 | 2004-12-16 | Gryphon Therapeutics, Inc. | Synthetic erythropoiesis stimulating proteins |
AU2002211744B8 (en) | 2000-10-11 | 2008-03-20 | Viron Therapeutics, Inc. | Nucleic acid molecules and polypeptides for immune modulation |
CA2428097A1 (en) | 2000-12-04 | 2002-06-13 | Viron Therapeutics, Inc. | Immunomodulatory protein derived from the yaba monkey tumor virus |
US7718368B2 (en) | 2000-12-04 | 2010-05-18 | Viron Therapeutics Inc. | Immunomodulatory protein and useful embodiments thereof |
DE10162869A1 (de) * | 2001-12-20 | 2003-07-31 | Alexander Cherkasky | Invasive lineare halb-zyklische und zyklische Systeme zur Herauslockung der Krankheitserreger |
GB0304531D0 (en) * | 2003-02-27 | 2003-04-02 | Isis Innovation | Treatment |
EP2266606B1 (en) * | 2003-05-15 | 2014-09-10 | Genentech, Inc. | Methods and compositions for the prevention and treatment of sepsis |
ES2297461T3 (es) | 2003-09-09 | 2008-05-01 | Fumapharm Ag | Uso de derivados del acido fumarico para tratar la insuficiencia cardiaca y el asma. |
EP2680009A1 (en) | 2007-02-08 | 2014-01-01 | Biogen Idec MA Inc. | Nrf2 screening assays and related methods and compositions |
CN113234137B (zh) * | 2021-06-21 | 2022-02-25 | 华中农业大学 | 分离自草鱼的CXCL20a蛋白在作为抗菌肽中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0604418T3 (da) * | 1991-03-29 | 1999-06-14 | Immunex Corp | Isolerede viralproteincytokinantagonister |
AU718049B2 (en) * | 1995-04-19 | 2000-04-06 | Viron Therapeutics, Inc. | Chemokine binding protein and methods of use therefor |
US5871740A (en) * | 1995-09-29 | 1999-02-16 | Immunex Corporation | Methods of using poxvirus p35 as a chemokine inhibitor and compositions therefore |
-
1997
- 1997-05-21 AT AT97926647T patent/ATE196091T1/de not_active IP Right Cessation
- 1997-05-21 JP JP09542675A patent/JP2000511535A/ja active Pending
- 1997-05-21 DE DE69703040T patent/DE69703040T2/de not_active Expired - Fee Related
- 1997-05-21 ES ES97926647T patent/ES2152095T3/es not_active Expired - Lifetime
- 1997-05-21 CA CA002256568A patent/CA2256568A1/en not_active Abandoned
- 1997-05-21 DK DK97926647T patent/DK0901379T3/da active
- 1997-05-21 AU AU31361/97A patent/AU3136197A/en not_active Abandoned
- 1997-05-21 EP EP97926647A patent/EP0901379B1/en not_active Expired - Lifetime
- 1997-05-21 TR TR1998/02392T patent/TR199802392T2/xx unknown
- 1997-05-21 WO PCT/US1997/008590 patent/WO1997044054A2/en not_active Application Discontinuation
- 1997-05-21 IL IL12716697A patent/IL127166A0/xx unknown
- 1997-05-21 CZ CZ983789A patent/CZ378998A3/cs unknown
- 1997-05-21 PL PL97330149A patent/PL330149A1/xx unknown
- 1997-05-21 PT PT97926647T patent/PT901379E/pt unknown
- 1997-05-21 CN CN97196663A patent/CN1226171A/zh active Pending
- 1997-05-21 BR BR9710028A patent/BR9710028A/pt not_active Application Discontinuation
- 1997-05-21 NZ NZ333456A patent/NZ333456A/xx unknown
- 1997-05-21 KR KR1019980709446A patent/KR20000015895A/ko not_active Application Discontinuation
-
1998
- 1998-11-20 NO NO985412A patent/NO985412L/no not_active Application Discontinuation
-
1999
- 1999-07-07 HK HK99102891A patent/HK1017622A1/xx not_active IP Right Cessation
-
2000
- 2000-11-10 GR GR20000402492T patent/GR3034805T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1997044054A3 (en) | 1998-05-14 |
JP2000511535A (ja) | 2000-09-05 |
EP0901379B1 (en) | 2000-09-06 |
DK0901379T3 (da) | 2000-12-27 |
CN1226171A (zh) | 1999-08-18 |
NO985412L (no) | 1999-01-20 |
ATE196091T1 (de) | 2000-09-15 |
ES2152095T3 (es) | 2001-01-16 |
PL330149A1 (en) | 1999-04-26 |
DE69703040T2 (de) | 2001-05-03 |
IL127166A0 (en) | 1999-09-22 |
WO1997044054A2 (en) | 1997-11-27 |
DE69703040D1 (de) | 2000-10-12 |
PT901379E (pt) | 2001-02-28 |
KR20000015895A (ko) | 2000-03-15 |
CA2256568A1 (en) | 1997-11-27 |
GR3034805T3 (en) | 2001-02-28 |
AU3136197A (en) | 1997-12-09 |
HK1017622A1 (en) | 1999-11-26 |
NZ333456A (en) | 2000-08-25 |
EP0901379A2 (en) | 1999-03-17 |
NO985412D0 (no) | 1998-11-20 |
CZ378998A3 (cs) | 1999-07-14 |
TR199802392T2 (xx) | 1999-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT840615E (pt) | Proteina de ligacao da quemoquina e metodos para a sua utilizacao | |
BR9710028A (pt) | Proteínas do tipo-2 que se ligam a quimiocina e métodos para a utilização das mesmas para esse fim | |
EA200000216A1 (ru) | Белки, связывающие интерлейкин-18, их получение и применение | |
DK0930366T3 (da) | Bindingsdomæner i Delta-proteiner | |
WO2002032925A3 (en) | Protein scaffolds for antibody mimics and other binding proteins | |
EP2267018A3 (en) | Binding polypeptides for B lymphocyte stimulator protein (BLyS) | |
BR0009206A (pt) | Isolamento e análise de proteina | |
ES537909A0 (es) | Procedimiento para la preparacion de anticuerpos contra digitalis | |
ATE142789T1 (de) | Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür | |
BR0109846A (pt) | Uso de uma composição que compreende um anticorpo ou um fragmento de ligação de antìgeno deste, e conjunto | |
FI970979A (fi) | Muokatut ihmisen C3-proteiinit | |
BR9709958A (pt) | Polipeptídeos capaz de formar estruturas de ligaçãode antígeno com especificidade para os antígenos de rhesus d o dna que os codifica e o processo para sua preparação e uso | |
DE69535855D1 (de) | Calciumbindende rekombinante antikörper gegen protein c | |
SE7909488L (sv) | Hemjernrikat aminosyrapreparat och forfarande for framstellning av hemjernrikade aminosyrapreparat fran hemproteiner | |
ES2185652T3 (es) | Oligopeptidos derivados de fragmentos de proteinas c-reactiva. | |
SE8502722D0 (sv) | Sett att bestemma vissa polypeptider samt medel for anvendning derfor | |
BR9808251B1 (pt) | vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma. | |
PT524421E (pt) | Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao | |
NO984233L (no) | Cytokin kalt lerk-8 | |
SE0003099D0 (sv) | Adhesive protein and uses therefore | |
EA199900663A1 (ru) | Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны | |
NO984522D0 (no) | Monoklonale antistoffer som binder humant veksthormon (hGH) | |
ES2183376T3 (es) | Uso de lbp para el tratamiento de la septicemia. | |
MY142458A (en) | Peptides that inhibit the propagation of newcastle disease virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |